These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1688514

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A pharmacokinetic and clinical evaluation of thio-TEPA in combination with cisplatin as first-line chemotherapy for advanced epithelial ovarian carcinoma.
    Hagen B, Onsrud M, Dale O.
    Int J Gynecol Cancer; 1999 Mar; 9(2):110-116. PubMed ID: 11240751
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    de Jonge ME, van Dam SM, Hillebrand MJ, Rosing H, Huitema AD, Rodenhuis S, Beijnen JH.
    J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quantification of N, N' N"-triethylenethiophosphoramide, N, N"-triethylenephosphoramide, cyclophosphamide, and 4-hydroxy-cyclophosphamide in microvolume human plasma to support neonatal and pediatric drug studies.
    Huang L, Winger BA, Cheah V, Gingrich D, Marzan F, Lu Y, Cooper JC, Aweeka F, Long-Boyle J.
    J Chromatogr Open; 2022 Nov; 2():. PubMed ID: 35875822
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Validation of a therapeutic drug monitoring strategy for thiotepa in a high-dose chemotherapy regimen.
    Huitema AD, Mathôt RA, Tibben MM, Rodenhuis S, Beijnen JH.
    Ther Drug Monit; 2001 Dec; 23(6):650-7. PubMed ID: 11802099
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR.
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion.
    Lokich JJ, Egorin MJ, Cohen BE, Bern MM, Zipoli TE, Moore C.
    Cancer; 1989 Jan 01; 63(1):46-50. PubMed ID: 2491952
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.